- Home
- LPSN vs ASRT Comparison
LPSN vs ASRT Comparison
Compare LPSN & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- ASRT
- Stock Information
- Founded
- LPSN 1995
- ASRT 1995
- Country
- LPSN United States
- ASRT United States
- Employees
- LPSN N/A
- ASRT N/A
- Industry
- LPSN EDP Services
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- ASRT Health Care
- Exchange
- LPSN Nasdaq
- ASRT Nasdaq
- Market Cap
- LPSN 93.7M
- ASRT 79.1M
- IPO Year
- LPSN 2000
- ASRT 1997
- Fundamental
- Price
- LPSN $0.70
- ASRT $0.98
- Analyst Decision
- LPSN Hold
- ASRT Strong Buy
- Analyst Count
- LPSN 1
- ASRT 1
- Target Price
- LPSN N/A
- ASRT $3.00
- AVG Volume (30 Days)
- LPSN 3.6M
- ASRT 222.4K
- Earning Date
- LPSN 11-06-2025
- ASRT 11-10-2025
- Dividend Yield
- LPSN N/A
- ASRT N/A
- EPS Growth
- LPSN N/A
- ASRT N/A
- EPS
- LPSN N/A
- ASRT N/A
- Revenue
- LPSN $271,750,000.00
- ASRT $117,099,000.00
- Revenue This Year
- LPSN N/A
- ASRT N/A
- Revenue Next Year
- LPSN N/A
- ASRT $5.84
- P/E Ratio
- LPSN N/A
- ASRT N/A
- Revenue Growth
- LPSN N/A
- ASRT N/A
- 52 Week Low
- LPSN $0.51
- ASRT $0.51
- 52 Week High
- LPSN $2.08
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- LPSN 32.00
- ASRT 78.79
- Support Level
- LPSN $0.51
- ASRT $0.79
- Resistance Level
- LPSN $1.01
- ASRT $0.83
- Average True Range (ATR)
- LPSN 0.07
- ASRT 0.04
- MACD
- LPSN -0.03
- ASRT 0.01
- Stochastic Oscillator
- LPSN 37.38
- ASRT 99.25
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.